TEACH: Tykerb evaluation after chemotherapy

Clin Breast Cancer. 2007 Feb;7(6):489-92. doi: 10.3816/CBC.2007.n.007.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Lapatinib
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Receptor, ErbB-2 / metabolism

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Quinazolines
  • Lapatinib
  • Receptor, ErbB-2